TY - JOUR
T1 - Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
AU - Liu, Xiaoli
AU - Ren, Fanggang
AU - Li, Shuo
AU - Zhang, Na
AU - Pu, Jeffrey J.
AU - Zhang, Hongyu
AU - Xu, Zhifang
AU - Tan, Yanhong
AU - Chen, Xiuhua
AU - Chang, Jianmei
AU - Wang, Hongwei
N1 - Funding Information: This work was supported by the National Natural Science Foundation of China (NO.81670126; NO.81500104), The Shanxi Natural Science Foundation of China (NO.201801D1110; NO.201801D22140903), Graduate Innovation Fund of Shanxi Province, The Second Hospital of Shanxi Medical University Doctoral Fund Project (202201-2), The Second Hospital of Shanxi Medical University Scientific and Technological Activities of Overseas Students Merit Grant Project (2020041), The Second Hospital of Shanxi Medical University Scientific Research Grant Project for Returned Overseas Students (2021-171), The Special Project of Jieping Wu Medical Foundation (320.6750.2022-8-4), The Second Hospital of Shanxi Medical University Youth Fund Project (201708). The Shanxi Technology Innovation Center for Controlled and Sustained Release of Nano-drugs (202104010911026). Publisher Copyright: © 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Aims: To investigate the mechanism of exosomes' role in the transformation of MDS to AML. Methods: Exosomes in culture supernatants of MDS and AML cell lines, were extracted by ultrafiltration and identified in three ways: morphology, size, and exosome protein surface markers. Exosomes from AML cell lines were then co-cultured with MDS cell lines and their impacts on MDS cell microenvironment, proliferation, differentiation, cell cycle, and apoptosis were analyzed by CCK-8 assay and flow cytometry. Furthermore, exosomes from MSC were extracted for further authentication. Results: The transmission electron microscopy, nanoparticle tracking analysis, Western blotting, and flow cytometry methods all verify that ultrafiltration is a reliable method to extract exosomes in the culture medium. Exosomes from AML cell lines inhibit the proliferation of MDS cell lines, block cell cycle progression, and promote apoptosis and cell differentiation. It also leads to increased secretion of tumor necrosis factor-α (TNF-α) and reactive oxygen species (ROS) in MDS cell lines. In addition, MSC-derived exosomes were found to inhibit the proliferation of MDS cell lines, arrest cell cycle progression, promote apoptosis, and inhibit differentiation. Conclusion: Ultrafiltration is a proper methodology in extracting exosomes. The exosomes of AML origin and MSC origin may play a role in MDS leukemia transformation via targeting TNF-α/ROS-Caspase3 pathway.
AB - Aims: To investigate the mechanism of exosomes' role in the transformation of MDS to AML. Methods: Exosomes in culture supernatants of MDS and AML cell lines, were extracted by ultrafiltration and identified in three ways: morphology, size, and exosome protein surface markers. Exosomes from AML cell lines were then co-cultured with MDS cell lines and their impacts on MDS cell microenvironment, proliferation, differentiation, cell cycle, and apoptosis were analyzed by CCK-8 assay and flow cytometry. Furthermore, exosomes from MSC were extracted for further authentication. Results: The transmission electron microscopy, nanoparticle tracking analysis, Western blotting, and flow cytometry methods all verify that ultrafiltration is a reliable method to extract exosomes in the culture medium. Exosomes from AML cell lines inhibit the proliferation of MDS cell lines, block cell cycle progression, and promote apoptosis and cell differentiation. It also leads to increased secretion of tumor necrosis factor-α (TNF-α) and reactive oxygen species (ROS) in MDS cell lines. In addition, MSC-derived exosomes were found to inhibit the proliferation of MDS cell lines, arrest cell cycle progression, promote apoptosis, and inhibit differentiation. Conclusion: Ultrafiltration is a proper methodology in extracting exosomes. The exosomes of AML origin and MSC origin may play a role in MDS leukemia transformation via targeting TNF-α/ROS-Caspase3 pathway.
KW - AML
KW - Exosomes
KW - MDS
KW - Mesenchymal stem cells
KW - Transformation
UR - http://www.scopus.com/inward/record.url?scp=85163896461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163896461&partnerID=8YFLogxK
U2 - 10.1007/s12672-023-00714-2
DO - 10.1007/s12672-023-00714-2
M3 - Article
SN - 1868-8497
VL - 14
JO - Discover Oncology
JF - Discover Oncology
IS - 1
M1 - 115
ER -